Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VITR.ST
- Price
- 151.90
- Stock movement up
- +0.40 (0.26%)
- Company name
- Vitrolife AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 20.57B
- Ent value
- 23.39B
- Price/Sales
- 5.79
- Price/Book
- 1.57
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 20.83%
- Trailing P/E
- -
- Forward P/E
- 26.71
- PEG
- -
- EPS growth
- -
- 1 year return
- -17.98%
- 3 year return
- -21.03%
- 5 year return
- -0.66%
- 10 year return
- 37.47%
Last updated: 2025-04-12
DIVIDENDS
VITR.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 25.37 |
| Price to FCF | 31.75 |
| Price to EBITDA | 17.38 |
| EV to EBITDA | 19.76 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.79 |
| Price to Book | 1.57 |
| EV to Sales | 6.58 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 135.45M |
| EPS (TTM) | -28.07 |
| FCF per share (TTM) | 4.78 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.55B |
| Gross profit (TTM) | 1.88B |
| Operating income (TTM) | 767.00M |
| Net income (TTM) | -3.81B |
| EPS (TTM) | -28.07 |
| EPS (1y forward) | 5.69 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 52.83% |
| Operating margin (TTM) | 21.59% |
| Profit margin (TTM) | -107.09% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 925.00M |
| Net receivables | 708.00M |
| Total current assets | 2.11B |
| Goodwill | 9.86B |
| Intangible assets | 4.32B |
| Property, plant and equipment | 0.00 |
| Total assets | 16.88B |
| Accounts payable | 190.00M |
| Short/Current long term debt | 2.05B |
| Total current liabilities | 724.00M |
| Total liabilities | 3.75B |
| Shareholder's equity | 13.14B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 811.00M |
| Capital expenditures (TTM) | 163.00M |
| Free cash flow (TTM) | 648.00M |
| Dividends paid (TTM) | 135.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -28.96% |
| Return on Assets | -22.54% |
| Return on Invested Capital | -25.20% |
| Cash Return on Invested Capital | 4.29% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 150.80 |
| Daily high | 153.20 |
| Daily low | 144.60 |
| Daily Volume | 525K |
| All-time high | 568.00 |
| 1y analyst estimate | 273.33 |
| Beta | 1.80 |
| EPS (TTM) | -28.07 |
| Dividend per share | - |
| Ex-div date | 26 Apr 2024 |
| Next earnings date | 16 Apr 2025 |
Downside potential
Loading...
Downside potential data
| VITR.ST | S&P500 | |
| Current price drop from All-time high | -73.26% | -12.89% |
| Highest price drop | -81.46% | -56.47% |
| Date of highest drop | 3 Jun 2013 | 9 Mar 2009 |
| Avg drop from high | -32.71% | -11.07% |
| Avg time to new high | 32 days | 12 days |
| Max time to new high | 1523 days | 1805 days |
COMPANY DETAILS
Marketcap
20.57B
Marketcap category
Large-cap
Description
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
Employees
1111
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Pär Ihrskog has been appointed CFO of the Vitrolife Group effective 10 October 2025. Pär currently serves as CFO at Bufab Group and brings a wealth of experience to the company, having also served as ...
April 10, 2025
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1 2025. The presentation will be held in English.
April 10, 2025
To further drive the execution of the Vitrolife Group corporate strategy, the company is evolving the executive management team and introducing a SVP Innovation role to accelerate the pace and output ...
March 31, 2025
Vitrolife Group has today published its Annual and Sustainability Report for 2024.
March 27, 2025
The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on 29 April 2025 at 4.00 pm at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Go...
March 25, 2025
Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no...
March 5, 2025
The Vitrolife Group is strengthening the executive management team with the introduction of the role of Chief Operating Officer (COO), appointing Ermanno Sironi to the position effective immediately.
February 21, 2025
Vitrolife AB Fourth quarter and full year report, 2024: A strong finish to the year
January 30, 2025
As global markets navigate the early days of President Trump's administration, U.S. stocks have been buoyed by optimism surrounding potential trade deals and AI-related investments, with major indices...
January 28, 2025
As global markets experience a rebound, driven by easing core inflation and strong earnings from the financial sector, investors are increasingly focused on identifying opportunities within value stoc...
January 20, 2025
Next page